Nancy Lurker - President & CEO, Eyepoint Pharmaceuticals, Inc
As of March 2, 2022
What is Nancy Lurker's Net Worth?
The current estimated net worth of Eyepoint Pharmaceuticals, Inc's President & CEO, Nancy Lurker, is estimated to be about $6.52M . Nancy Lurker owns about 103,546 units of Eyepoint Pharmaceuticals, Inc common stock. In the last 4 years at Eyepoint Pharmaceuticals, Inc, Nancy Lurker has sold an estimated value of $224.1K worth.
What is Nancy Lurker's Past Insider Trading?
Nancy Lurker's largest purchase order was 98,000 units , worth over $104.03K on March 11, 2020. Nancy Lurker's largest sale order was 10,000 units , worth over $201.48K on November 17, 2021. In total, Nancy Lurker has made about 22 transactions over 4 years of their time at Eyepoint Pharmaceuticals, Inc. Nancy Lurker usually trades in June, with the busiest year in 2020.
Nancy Lurker
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Nancy Lurker's Salary in 2020?
As President & CEO of Eyepoint Pharmaceuticals, Inc, Nancy Lurker has a total base salary of $581,957 . Nancy Lurker received compensation valued at about $2,097,801 in 2020 after becoming President & CEO. The vast majority of their compensation came in the form of stock awards of $482,460 , option awards of $563,216 , other earnings, plans or compensations of $454,508 , and other compensation of $15,660 .
What is Nancy Lurker's' Mailing Address?
- Mailing address is Pdi, Inc. 1 Route 17 South Saddle River NJ 07458 NJ
Eyepoint Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Nancy Lurker | 2020 | $581,957 | - | $482,460 | $563,216 | $454,508 | $15,660 | $2,097,801 |
| Nancy Lurker | 2019 | $577,037 | - | $650,207 | $693,165 | $144,034 | $15,340 | $2,079,783 |
| George Elston | 2020 | $440,000 | - | - | $83,104 | $236,940 | $15,660 | $775,704 |
| George Elston | 2019 | $58,385 | $20,000 | - | $635,555 | - | $2,068 | $716,008 |
| Dario Paggiarino | 2020 | $436,156 | - | $158,864 | $185,417 | $242,371 | $15,660 | $1,038,468 |
| Dario Paggiarino | 2019 | $420,862 | - | - | $275,775 | $105,188 | $15,340 | $817,165 |
| Scott Jones | 2020 | $376,250 | - | $158,864 | $185,417 | $212,135 | $15,660 | $948,326 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1314102/000156459021022639/eypt-def14a_20210622.htm
What are Eyepoint Pharmaceuticals, Inc's Past Insider Trades?
Eyepoint Pharmaceuticals, Inc's most recent insider trade came on March 15, 2022 by Craig Michael Pine who bought 1,000 units worth $12.21K . In the last 4 years, insiders at Eyepoint Pharmaceuticals, Inc have sold an estimated value of $448.9K and bought an estimated value of $22.04M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Nancy Lurker, President & CEO, Dario Paggiarino, Chief Medical Officer, and David Mazzo .
EyePoint Pharmaceuticals, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||